scispace - formally typeset
B

Barry S. Komm

Researcher at Pfizer

Publications -  154
Citations -  12096

Barry S. Komm is an academic researcher from Pfizer. The author has contributed to research in topics: Selective estrogen receptor modulator & Bazedoxifene. The author has an hindex of 51, co-authored 152 publications receiving 11487 citations. Previous affiliations of Barry S. Komm include University of Arizona.

Papers
More filters
Journal ArticleDOI

Canonical WNT Signaling Promotes Osteogenesis by Directly Stimulating Runx2 Gene Expression

TL;DR: It is proposed that WNT/TCF1 signaling, like bone morphogenetic protein/transforming growth factor-β signaling, activates Runx2 gene expression in mesenchymal cells for the control of osteoblast differentiation and skeletal development.
Journal ArticleDOI

Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype.

TL;DR: The use of global gene expression profiling by Affymetrix GeneChip microarray analysis to identify patterns and time courses of genes that are either stimulated or inhibited by estradiol (E2) in estrogen receptor (ER)-positive MCF-7 human breast cancer cells is highlighted.
Journal ArticleDOI

Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells

TL;DR: Estradiol can act directly on osteoblasts by a receptor-mediated mechanism and thereby modulate the extracellular matrix and other proteins involved in the maintenance of skeletal mineralization and remodeling.
Journal ArticleDOI

Selective estrogen receptor modulators: discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells.

TL;DR: In this paper, the effects of tamoxifen and raloxifene on the expression of approximately 12,000 genes, using Affymetrix GeneChip microarrays, with quantitative PCR verification in many cases.
Journal ArticleDOI

Wnt/β-Catenin Signaling Is a Normal Physiological Response to Mechanical Loading in Bone

TL;DR: In vivo and in vitro mechanical loading results support that Wnt/β-catenin signaling is a normal physiological response to load and that activation of the Wnt /β- catenin pathway enhances the sensitivity of osteoblasts/osteocytes to mechanical loading.